Celgene Corporation


Cowen Maintains Outperform On Celgene Following ASH Meeting; Keeps $110 PT

Cowen analyst Eric Schmidt maintained an Outperform rating on Celgene Corporation (NASDAQ:CELG) with a price target of $110, which, surprisingly, represents a potential …

We Continue To Like Celgene Shares, Says Cantor

In a research report issued today, Cantor analyst Mara Goldstein reiterated a Buy rating on Celgene Corporation (NASDAQ:CELG) and raised her price target …

Celgene: Pipeline To Drive Upside, Overhangs Could Be Removed Near-Term, Says Deutsche Bank

In a research report released today, Deutsche Bank analyst Robyn Karnauskas assigned a Buy rating on Celgene Corporation (NASDAQ:CELG) and raised her share price target …

Celgene: Purchasing Shares At These Levels Would Be Appropriate, Says William Blair

In a research report released yesterday, William Blair analyst John Sonnier reiterated an Outperform rating on Celgene Corporation (CELG) following yesterday’s news that the phase …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts